32 related articles for article (PubMed ID: 29677589)
1. "Homozygous, and compound heterozygous mutation in 3 Turkish family with Jervell and Lange-Nielsen syndrome: case reports".
Uysal F; Turkgenc B; Toksoy G; Bostan OM; Evke E; Uyguner O; Yakicier C; Kayserili H; Cil E; Temel SG
BMC Med Genet; 2017 Oct; 18(1):114. PubMed ID: 29037160
[TBL] [Abstract][Full Text] [Related]
2. Novel combinations of variations in KCNQ1 were associated with patients with long QT syndrome or Jervell and Lange-Nielsen syndrome.
Zhao N; Yu Z; Cai Z; Chen W; He X; Huo Z; Lin X
BMC Cardiovasc Disord; 2023 Aug; 23(1):399. PubMed ID: 37568094
[TBL] [Abstract][Full Text] [Related]
3. The electrophysiologic effects of KCNQ1 extend beyond expression of IKs: evidence from genetic and pharmacologic block.
Wada Y; Wang L; Hall LD; Yang T; Short LL; Solus JF; Glazer AM; Roden DM
Cardiovasc Res; 2024 May; 120(7):735-744. PubMed ID: 38442735
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
[TBL] [Abstract][Full Text] [Related]
5. Jervell and Lange-Nielsen syndrome with novel KCNQ1 and additional gene mutations.
Matsuda S; Ohnuki Y; Okami M; Ochiai E; Yamada S; Takahashi K; Osawa M; Okami K; Iida M; Mochizuki H
Hum Genome Var; 2020; 7():34. PubMed ID: 33082985
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell line from patient with atrial fibrillation with KCNQ1 p.Ser209Pro mutation.
Cen Y; Zhou T; Chen S; Deng Z; Wang J; Ma N; Zhang S
Stem Cell Res; 2024 Apr; 76():103336. PubMed ID: 38341987
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (SYSUSCi001-A) from a congenital cataract patient carrying heterozygous mutations in BFSP1 and RHO.
Chen F; Wang T; Yang Y; Huang Z; Dong Y; Zhang R; Chen J; Zhou Q
Stem Cell Res; 2022 Mar; 59():102644. PubMed ID: 34995847
[TBL] [Abstract][Full Text] [Related]
8. Turkish perspective of Jervell and Lange-Nielsen syndrome.
Temel SG; Bostan OM; Cangul H; Cil E
Ann Indian Acad Neurol; 2013 Jan; 16(1):129-30. PubMed ID: 23661983
[No Abstract] [Full Text] [Related]
9. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.
Mura M; Ginevrino M; Zappatore R; Pisano F; Boni M; Castelletti S; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
Stem Cell Res; 2018 May; 29():170-173. PubMed ID: 29684900
[TBL] [Abstract][Full Text] [Related]
10. Establishment of STUB1/CHIP mutant induced pluripotent stem cells (iPSCs) from a patient with Gordon Holmes syndrome/SCAR16.
Schuster S; Schelling Y; Synofzik M; Höflinger P; Schöls L; Hauser S
Stem Cell Res; 2018 May; 29():166-169. PubMed ID: 29679845
[TBL] [Abstract][Full Text] [Related]
11. From Pluripotent Stem to CAR T Cells.
Cancer Discov; 2018 Jun; 8(6):OF5. PubMed ID: 29678834
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human induced pluripotent stem cell line from urinary cells of a patient with primary congenital glaucoma using integration free Sendai technology.
Zhang J; Wu S; Hu M; Liu Q
Stem Cell Res; 2018 May; 29():162-165. PubMed ID: 29677590
[TBL] [Abstract][Full Text] [Related]
13. Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19.
Sala L; Leonov V; Mura M; Giannetti F; Khudiakov A; Moretti A; Crotti L; Gnecchi M; Schwartz PJ
Front Physiol; 2021; 12():730127. PubMed ID: 35153806
[TBL] [Abstract][Full Text] [Related]
14. Long QT Syndrome: Genetics and Future Perspective.
Wallace E; Howard L; Liu M; O'Brien T; Ward D; Shen S; Prendiville T
Pediatr Cardiol; 2019 Oct; 40(7):1419-1430. PubMed ID: 31440766
[TBL] [Abstract][Full Text] [Related]
15. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene.
Mura M; Lee YK; Ginevrino M; Zappatore R; Pisano F; Boni M; Dagradi F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2018 May; 29():157-161. PubMed ID: 29677589
[TBL] [Abstract][Full Text] [Related]
16. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.
Zhang M; D'Aniello C; Verkerk AO; Wrobel E; Frank S; Ward-van Oostwaard D; Piccini I; Freund C; Rao J; Seebohm G; Atsma DE; Schulze-Bahr E; Mummery CL; Greber B; Bellin M
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5383-92. PubMed ID: 25453094
[TBL] [Abstract][Full Text] [Related]
17. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.
Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2019 May; 37():101437. PubMed ID: 31009818
[TBL] [Abstract][Full Text] [Related]
18. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.
Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2019 May; 37():101431. PubMed ID: 30974404
[TBL] [Abstract][Full Text] [Related]
19. [Jervell and Lange-Nielsen syndrome].
Zhang WJ; Sun Y; Kong WJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):825-829. PubMed ID: 31446697
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
